NovoCure Ltd’s filing revealed that its Chief Executive Officer Cordova Ashley acquired Company’s shares for reported $1.0 million on Sep 05 ’25. In the deal valued at $12.22 per share,81,550 shares were bought. As a result of this transaction, Cordova Ashley now holds 437,569 shares worth roughly $6.2 million.
Then, Brackmann Christoph bought 20,000 shares, generating $231,800 in total proceeds. Upon buying the shares at $11.59, the Chief Financial Officer now owns 141,150 shares.
Before that, Stafford Kristin sold 999 shares. NovoCure Ltd shares valued at $17,259 were divested by the Director at a price of $17.28 per share. As a result of the transaction, Stafford Kristin now holds 3,054 shares, worth roughly $43305.72.
Wells Fargo downgraded its NovoCure Ltd [NVCR] rating to an Equal weight from a an Overweight in a research note published recently. A number of analysts have revised their coverage, including Ladenburg Thalmann’s analysts, who began to cover the stock in early July with a ‘”a Buy”‘ rating. Evercore ISI also remained covering NVCR and has increased its forecast on December 02, 2024 with a “an Outperform” recommendation from previously “an In-line” rating. H.C. Wainwright revised its rating on October 16, 2024. It rated NVCR as “a Buy” which previously was an “a Neutral”.
Price Performance Review of NVCR
On Monday, NovoCure Ltd [NASDAQ:NVCR] saw its stock fall -1.18% to $14.18. Over the last five days, the stock has gained 2.98%. NovoCure Ltd shares have fallen nearly -50.95% since the year began. Nevertheless, the stocks have risen 9.67% over the past one year.
How much short interest is there in NovoCure Ltd?
A steep rise in short interest was recorded in NovoCure Ltd stocks on 2025-12-31, growing by 1.51 million shares to a total of 8.33 million shares. Yahoo Finance data shows the prior-month short interest on 2025-11-28 was 6.83 million shares. There was a rise of 18.08%, which implies that there is a positive sentiment for the stock.
